Connection

Maria Lopes-Virella to Animals

This is a "connection" page, showing publications Maria Lopes-Virella has written about Animals.
Connection Strength

0.497
  1. Modified LDL Immune Complexes and Cardiovascular Disease. Curr Med Chem. 2019; 26(9):1680-1692.
    View in: PubMed
    Score: 0.047
  2. Clinical significance of the humoral immune response to modified LDL. Clin Immunol. 2010 Jan; 134(1):55-65.
    View in: PubMed
    Score: 0.024
  3. Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis. 2008 Oct; 200(2):239-46.
    View in: PubMed
    Score: 0.022
  4. Development of capture assays for different modifications of human low-density lipoprotein. Clin Diagn Lab Immunol. 2005 Jan; 12(1):68-75.
    View in: PubMed
    Score: 0.018
  5. Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies. J Lipid Res. 2004 Oct; 45(10):1859-67.
    View in: PubMed
    Score: 0.017
  6. The role of immune and inflammatory processes in the development of macrovascular disease in diabetes. Front Biosci. 2003 Sep 01; 8:s750-68.
    View in: PubMed
    Score: 0.016
  7. Lipoprotein autoantibodies: measurement and significance. Clin Diagn Lab Immunol. 2003 Jul; 10(4):499-505.
    View in: PubMed
    Score: 0.016
  8. Humoral immunity and atherosclerosis. Nat Med. 2003 Mar; 9(3):243-4; author reply 244-5.
    View in: PubMed
    Score: 0.016
  9. Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis. PLoS One. 2022; 17(11):e0277251.
    View in: PubMed
    Score: 0.015
  10. High-fat diet-induced metabolic syndrome increases ligature-induced alveolar bone loss in mice. Oral Dis. 2023 Apr; 29(3):1312-1323.
    View in: PubMed
    Score: 0.014
  11. Inhibition of acid sphingomyelinase by imipramine abolishes the synergy between metabolic syndrome and periodontitis on alveolar bone loss. J Periodontal Res. 2022 Jan; 57(1):173-185.
    View in: PubMed
    Score: 0.014
  12. Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells. Metabolism. 2001 Jan; 50(1):99-106.
    View in: PubMed
    Score: 0.013
  13. GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice. Am J Physiol Endocrinol Metab. 2021 01 01; 320(1):E30-E42.
    View in: PubMed
    Score: 0.013
  14. Acid sphingomyelinase deficiency exacerbates LPS-induced experimental periodontitis. Oral Dis. 2020 Apr; 26(3):637-646.
    View in: PubMed
    Score: 0.013
  15. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. Am J Physiol Endocrinol Metab. 2020 02 01; 318(2):E131-E144.
    View in: PubMed
    Score: 0.013
  16. Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages. Arterioscler Thromb Vasc Biol. 1999 Jul; 19(7):1600-7.
    View in: PubMed
    Score: 0.012
  17. Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro. Am J Physiol Endocrinol Metab. 2018 11 01; 315(5):E745-E757.
    View in: PubMed
    Score: 0.011
  18. LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages. J Leukoc Biol. 2018 10; 104(4):843-853.
    View in: PubMed
    Score: 0.011
  19. Docosahexaenoic acid antagonizes the boosting effect of palmitic acid on LPS inflammatory signaling by inhibiting gene transcription and ceramide synthesis. PLoS One. 2018; 13(2):e0193343.
    View in: PubMed
    Score: 0.011
  20. Cooperative stimulation of atherogenesis by lipopolysaccharide and?palmitic acid-rich high fat diet in low-density lipoprotein receptor-deficient mice. Atherosclerosis. 2017 10; 265:231-241.
    View in: PubMed
    Score: 0.011
  21. CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate. Oral Dis. 2017 Mar; 23(2):210-218.
    View in: PubMed
    Score: 0.010
  22. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization. J Lipid Res. 2017 02; 58(2):325-338.
    View in: PubMed
    Score: 0.010
  23. F(ab')2 fragments of anti-oxidized LDL IgG attenuate vascular inflammation and atherogenesis in diabetic LDL receptor-deficient mice. Clin Immunol. 2016 Dec; 173:50-56.
    View in: PubMed
    Score: 0.010
  24. Modification of lipoproteins in diabetes. Diabetes Metab Rev. 1996 Apr; 12(1):69-90.
    View in: PubMed
    Score: 0.010
  25. Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol. 1996 Feb; 16(2):222-9.
    View in: PubMed
    Score: 0.010
  26. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes. Immunobiology. 2015 Nov; 220(11):1246-54.
    View in: PubMed
    Score: 0.009
  27. Metabolic syndrome exacerbates inflammation and bone loss in periodontitis. J Dent Res. 2015 Feb; 94(2):362-70.
    View in: PubMed
    Score: 0.009
  28. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol. 1994 Nov; 73(2):155-67.
    View in: PubMed
    Score: 0.009
  29. Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome. J Dent Res. 2014 Mar; 93(3):294-9.
    View in: PubMed
    Score: 0.008
  30. MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-? and high glucose in mononuclear cells?-?a potential role of MD-2 in Toll-like receptor 4-independent signalling. Immunology. 2013 Nov; 140(3):301-13.
    View in: PubMed
    Score: 0.008
  31. Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease. J Periodontal Res. 2014 Aug; 49(4):518-26.
    View in: PubMed
    Score: 0.008
  32. Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release. Immunology. 2012 May; 136(1):30-45.
    View in: PubMed
    Score: 0.007
  33. DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice. J Cardiovasc Pharmacol. 2011 Aug; 58(2):157-66.
    View in: PubMed
    Score: 0.007
  34. Insulin treatment attenuates diabetes-increased atherosclerotic intimal lesions and matrix metalloproteinase 9 expression in apolipoprotein E-deficient mice. J Endocrinol. 2011 Jul; 210(1):37-46.
    View in: PubMed
    Score: 0.007
  35. Immune mechanisms in the pathogenesis of atherosclerosis. Adv Exp Med Biol. 1991; 285:383-92.
    View in: PubMed
    Score: 0.007
  36. Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress. PLoS One. 2010 Sep 02; 5(9).
    View in: PubMed
    Score: 0.007
  37. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. J Lipid Res. 2010 Sep; 51(9):2619-28.
    View in: PubMed
    Score: 0.006
  38. Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages. J Biol Chem. 2010 May 21; 285(21):15985-93.
    View in: PubMed
    Score: 0.006
  39. A review of the development of large-vessel disease in diabetes mellitus. Am J Med. 1988 Nov 28; 85(5A):113-8.
    View in: PubMed
    Score: 0.006
  40. Infections and atherosclerosis. Transplant Proc. 1987 Aug; 19(4 Suppl 5):26-35.
    View in: PubMed
    Score: 0.005
  41. Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice. Atherosclerosis. 2007 May; 192(1):85-91.
    View in: PubMed
    Score: 0.005
  42. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. J Lab Clin Med. 1985 Sep; 106(3):319-25.
    View in: PubMed
    Score: 0.001
  43. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80.
    View in: PubMed
    Score: 0.001
  44. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. J Lab Clin Med. 1983 Nov; 102(5):795-804.
    View in: PubMed
    Score: 0.001
  45. Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes. Immunology. 1983 Sep; 50(1):43-51.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.